| The Cancer Genome Atlas Pan-Cancer analysis project TCGAR Network Nature Genetics 45 (10), 1113-1120, 2013 | 6871* | 2013 |
| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ... Cell 161 (7), 1681-1696, 2015 | 2787 | 2015 |
| The Molecular Taxonomy of Primary Prostate Cancer CGA Network Cell 163 (4), 1011-25, 2015 | 2709* | 2015 |
| Systematic analysis of telomere length and somatic alterations in 31 cancer types FP Barthel, W Wei, M Tang, E Martinez-Ledesma, X Hu, SB Amin, ... Nature genetics 49 (3), 349-357, 2017 | 604 | 2017 |
| Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 546 | 2020 |
| Longitudinal molecular trajectories of diffuse glioma in adults FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ... Nature 576 (7785), 112-120, 2019 | 438 | 2019 |
| Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma RH Prabhala, D Pelluru, M Fulciniti, HK Prabhala, P Nanjappa, W Song, ... Blood, The Journal of the American Society of Hematology 115 (26), 5385-5392, 2010 | 407 | 2010 |
| Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers H Kim, NP Nguyen, K Turner, S Wu, AD Gujar, J Luebeck, J Liu, ... Nature genetics 52 (9), 891-897, 2020 | 348 | 2020 |
| Glioma progression is shaped by genetic evolution and microenvironment interactions FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ... Cell, 2022 | 237 | 2022 |
| TumorFusions: an integrative resource for cancer-associated transcript fusions X Hu, Q Wang, M Tang, F Barthel, S Amin, K Yoshihara, FM Lang, ... Nucleic acids research 46 (D1), D1144-D1149, 2018 | 212 | 2018 |
| TumorFusions: an integrative resource for reporting cancer-associated transcript fusions in 33 tumor types X Hu, Q Wang, F Barthel, M Tang, S Amin, K Yoshihara, FM Lang, SH Lee, ... bioRxiv, 162180, 2017 | 212* | 2017 |
| KMT2D deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer H Alam, M Tang, M Maitituoheti, SS Dhar, M Kumar, CY Han, CR Ambati, ... Cancer cell 37 (4), 599-617. e7, 2020 | 175 | 2020 |
| Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium Neuro-oncology 20 (7), 873-884, 2018 | 137 | 2018 |
| Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer G Genovese, A Carugo, J Tepper, FS Robinson, L Li, M Svelto, L Nezi, ... Nature 542 (7641), 362-366, 2017 | 127 | 2017 |
| Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure KC Akdemir, VT Le, JM Kim, S Killcoyne, DA King, YP Lin, Y Tian, A Inoue, ... Nature Genetics 52 (11), 1178-1188, 2020 | 116 | 2020 |
| Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancer E Kocakavuk, KJ Anderson, FS Varn, KC Johnson, SB Amin, E Sulman, ... Nature genetics 53 (7), 1088-1096, 2021 | 104 | 2021 |
| Live-Cell Imaging Shows Uneven Segregation of Extrachromosomal DNA Elements and Transcriptionally Active Extrachromosomal DNA Hubs in CancerInheritance and Transcriptional … E Yi, AD Gujar, M Guthrie, H Kim, D Zhao, KC Johnson, SB Amin, ... Cancer Discovery 12 (2), 468-483, 2022 | 95 | 2022 |
| Systematic epigenomic analysis reveals chromatin states associated with melanoma progression P Fiziev, KC Akdemir, JP Miller, EZ Keung, NS Samant, S Sharma, ... Cell reports 19 (4), 875-889, 2017 | 92 | 2017 |
| miR-182-5p induced by STAT3 activation promotes glioma tumorigenesis J Xue, A Zhou, Y Wu, SA Morris, K Lin, S Amin, R Verhaak, G Fuller, K Xie, ... Cancer research 76 (14), 4293-4304, 2016 | 92 | 2016 |
| Gene expression profile alone is inadequate in predicting complete response in multiple myeloma SB Amin, WK Yip, S Minvielle, A Broyl, Y Li, B Hanlon, D Swanson, ... Leukemia 28 (11), 2229-2234, 2014 | 88 | 2014 |
Chris SanderHarvard Medical School, Broad Institute, Dana-Farber Cancer Institute, Memorial Sloan KetteringBestätigte E-Mail-Adresse bei sanderlab.org
